In the above screening, we focused on HIPK2 because low HIPK2 expression is associated with poor prognosis in pancreatic cancer, and HIPK2 is associated with tumor suppressor p53, one of the major molecules underlying PDAC tumorigenesis. This evidence concerns the gene HIPK2 and pancreatic neoplasm.